Single-Row Versus Double-Row Repair for Achilles Insertional Tendinopathy
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-75
SponsorWomen's College Hospital
About this trial
Achilles insertional tendinopathy may require surgical debridement and tendon reattachment when non-operative treatment fails. Single-row and double-row repairs are used, with biomechanical studies favoring double-row, but clinical evidence of improved outcomes is lacking and costs are higher. This multi-center randomized trial will use the VISA-A score to compare outcomes and inform cost-effective, evidence-based surgical care.
Eligibility criteria
Qualifiers
Must be deemed to have capacity to provide informed consent;
Must sign and date the informed consent form;
Stated willingness to comply with all study procedures;
Adult patients between the ages of 18 and 75 years with symptomatic chronic Achilles insertional tendinopathy for a minimum of 3 months
Disqualifiers
Non-insertional Achilles tendinopathy;
Achilles tendon rupture;
Previous Achilles tendon surgery;
Oral steroid use or steroid injection within 3 months of surgery;
Trial design
Treatments tested in this trial
- Single-row repair of the Achilles tendon at its calcaneal insertion
- Double-row repair of the Achilles tendon at its calcaneal insertion
Treatment groups
166 Participants
are divided into 2 treatment groupsSponsors and collaborators
Women's College Hospital
Lead sponsor
The Physicians' Services Incorporated Foundation
Collaborator
University Health Network, Toronto
Collaborator
Unity Health Toronto
Collaborator
University of Toronto
Collaborator
Source ClinicalTrials.gov